Lipid-Derived Biomarkers for NAION

TVST study reveals potential new metabolic signal in nonarteritic anterior ischemic optic neuropathy

March 13, 2026
4 min

The Ophthalmologist

Overview

A recent study investigates the potential of lipid-derived indices, specifically the atherogenic index of plasma (AIP) and triglyceride–glucose (TyG) index, as biomarkers for nonarteritic anterior ischemic optic neuropathy (NAION). The findings suggest these indices may reflect systemic metabolic vulnerability associated with NAION, even in patients without overt hyperlipidemia.

Background

Nonarteritic anterior ischemic optic neuropathy (NAION) is a significant condition in ophthalmology, characterized by sudden vision loss due to ischemia of the optic nerve. Despite the recognition of systemic vascular risk factors, there are currently no established biomarkers to aid in diagnosis or risk stratification. Understanding the metabolic underpinnings of NAION could enhance clinical management and patient outcomes.

Data Highlights

Parameter	NAION Group	Control Group
Triglycerides	Higher	Lower
HDL-C	Lower	Higher
AIP	Elevated	Normal
TyG Index	Elevated	Normal

Key Findings

Both AIP and TyG indices were significantly elevated in NAION patients compared to controls.
Traditional lipid parameters were largely within normal limits in both groups.
Neither AIP nor TyG correlated with functional or structural severity measures in NAION.
Elevated AIP indicates a more atherogenic lipid profile, while TyG serves as a surrogate marker of insulin resistance.
The study suggests that NAION may represent a systemic metabolic disease rather than solely a local optic nerve event.

Clinical Implications

The findings indicate that lipid-derived indices may provide insights into the systemic metabolic status of NAION patients, particularly those without overt dyslipidemia. While these markers are not yet ready to influence clinical management, they highlight the need for expanded metabolic profiling in unexplained NAION cases.

Conclusion

This study contributes to the understanding of NAION as potentially linked to systemic metabolic factors, suggesting that lipid metabolism may play a more significant role in optic nerve ischemia than previously recognized.